Clinical Research and Protocol Support Services
临床研究和方案支持服务
基本信息
- 批准号:10930600
- 负责人:
- 金额:$ 956.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Age related macular degenerationAutoimmuneBlood VesselsCataractClinicClinicalClinical DataClinical InformaticsClinical InvestigatorClinical ProtocolsClinical ResearchClinical Research ProtocolsClinical TrialsCollaborationsCommunitiesConsultConsultationsCredentialingDevelopmentDiagnosisDiagnosticDiagnostic ServicesDiseaseEducationEnsureEyeEye diseasesFellowshipFosteringFundingGeneticGrantHealth PersonnelImageInflammationInfrastructureInheritedInstitutional Review BoardsIntramural Research ProgramInvestigationLaboratory ResearchLasersLeadMarylandMetastatic MelanomaMethodologyMonitorNational Eye InstituteNational Heart, Lung, and Blood InstituteNational Institute of Allergy and Infectious DiseaseNeurocysticercosisNutritionalOffice ManagementOphthalmologyPathologyPatient CarePatientsPhasePhysiciansPreventionProcessProtocols documentationResearch PersonnelResearch TrainingResourcesRetinal gene therapySafety ManagementServicesSourceStudentsSystemTestingTimeTrainingTranslationsTravelUnited States National Institutes of HealthVisionVisual SystemWegener&aposs Granulomatosisclinical applicationclinical careclinical centerdata managementdesigndiabeticgraft vs host diseasehigh riskimagerinnovationmacular edemamotor disordermultidisciplinaryneovascularizationoff-label drugoutpatient facilitypatient safetypharmacologicprogramsquality assuranceskillstesting services
项目摘要
The clinical program is centrally managed by the Office of the Clinical Director http://www.nei.nih.gov/intramural/cbranch.asp which consists of a state-of-the-art outpatient facility and a multidisciplinary team of ophthalmic physicians, ophthalmic imagers, ophthalmic technicians, and clinical research coordinators, all highly skilled and trained to support clinical research.
The Office of the Clinical Director continues to provide core clinical research service support to the National Eye Institute investigator during all phases of the clinical research protocol approvals process from concept to approval by the CNS-IRB and until completion. This support includes; diagnostic, statistical, protocol design, coordinating, regulatory, management, and clinical facilities that enable NEI clinical investigators to focus their time and resources on developing and conducting innovative and high-risk clinical research. This support covered, on average, 40 plus active protocols. A complete description of NEI's intramural scientific portfolio can be found at http://www.nei.nih.gov/intramural/. Specific NEI clinical trials being conducted at the Warren Grant Magnuson Clinical Center in Bethesda, Maryland can be found at http://clinicalstudies.info.nih.gov/cgi/protinstitute.cgi?NEI.0.html and include among others: imaging/diagnostic, diabetic macular edema, cataract, and vision motor disorders; nutritional, pharmacologic, and/or gene therapies for retinal vascular and genetically-inherited ocular diseases; and laser approaches and supplemental methodologies for neovascularization in age-related macular degeneration.
In addition, the Office of the Clinical Director provides ophthalmic consult services to the NIH community. These consultations provide an interesting mix of rare pathologies such as neurocysticercosis (NIAID), metastatic melanoma-a disease with autoimmune ocular inflammation (NCI), graft versus host disease with ocular involvement (NHLBI), and Wegener's granulomatosis (NIAID) which has fostered longterm collaborations and has lead to clinical trials and additional investigations.
该临床项目由临床主任办公室(http://www.nei.nih.gov/intramural/cbranch.asp)集中管理,该办公室由最先进的门诊设施和眼科医生、眼科成像师、眼科技术人员和临床研究协调员组成的多学科团队组成,所有人员都训练有素,训练有素,能够支持临床研究。
在临床研究方案批准过程的所有阶段,从概念到CNS-IRB批准,直至完成,临床主任办公室继续为国家眼科研究所研究者提供核心临床研究服务支持。这种支持包括;诊断、统计、方案设计、协调、监管、管理和临床设施,使NEI临床研究者能够将时间和资源集中在开发和开展创新和高风险的临床研究上。这一支持平均涵盖40多项现行协议。NEI校内科学组合的完整描述可以在http://www.nei.nih.gov/intramural/上找到。在马里兰州贝塞斯达的Warren Grant Magnuson临床中心进行的具体NEI临床试验可在http://clinicalstudies.info.nih.gov/cgi/protinstitute.cgi?上找到NEI.0.html,其中包括:成像/诊断,糖尿病性黄斑水肿,白内障和视觉运动障碍;视网膜血管和遗传性眼病的营养,药理学和/或基因疗法;以及年龄相关性黄斑变性中新生血管形成的激光方法和补充方法。
此外,临床主任办公室还为NIH社区提供眼科咨询服务。这些咨询提供了一个有趣的混合罕见的病理,如神经囊尾蚴病(NIAID),转移性黑色素瘤-一种疾病与自身免疫性眼部炎症(NCI),移植物抗宿主病与眼部受累(NHLBI),韦格纳肉芽肿病(NIAID),这促进了长期的合作,并导致临床试验和其他调查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William O'Donnell其他文献
William O'Donnell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William O'Donnell', 18)}}的其他基金
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Study of Neuropilin-1 as a potential marker of self-reactive Th cells in autoimmune neuroinflammation
Neuropilin-1 作为自身免疫性神经炎症中自身反应性 Th 细胞潜在标志物的研究
- 批准号:
24K10278 - 财政年份:2024
- 资助金额:
$ 956.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Shared and distinct genetic architecture of autoimmune and hormonal alopecias
自身免疫性脱发和激素性脱发的共同和独特的遗传结构
- 批准号:
MR/X030466/1 - 财政年份:2024
- 资助金额:
$ 956.18万 - 项目类别:
Research Grant
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 956.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Environmental factors and risk of autoimmune rheumatic disease incidence and serology
环境因素和自身免疫性风湿病发病率和血清学的风险
- 批准号:
498306 - 财政年份:2023
- 资助金额:
$ 956.18万 - 项目类别:
Operating Grants
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 956.18万 - 项目类别:
Operating Grants
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
- 批准号:
493526 - 财政年份:2023
- 资助金额:
$ 956.18万 - 项目类别:
Operating Grants
Functional consequences of intergenic autoimmune disease risk variants
基因间自身免疫性疾病风险变异的功能后果
- 批准号:
10655161 - 财政年份:2023
- 资助金额:
$ 956.18万 - 项目类别:
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 956.18万 - 项目类别:
PTSD and Autoimmune Disease: Towards Causal Effects, Risk Factors, and Mitigators
创伤后应激障碍 (PTSD) 和自身免疫性疾病:因果效应、危险因素和缓解措施
- 批准号:
10696671 - 财政年份:2023
- 资助金额:
$ 956.18万 - 项目类别:
Build to LEAD – Building partnerships to Link the Exposome to Autoimmune Disease
构建引领 — 建立合作伙伴关系,将暴露组与自身免疫性疾病联系起来
- 批准号:
10871040 - 财政年份:2023
- 资助金额:
$ 956.18万 - 项目类别: